Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Morrison, Nigel A ^a   Stephens, Alexandre A ^a   Osato, Motomi ^b   Polly, Patsie ^c   Tan, Timothy C ^c   Yamashita, Namiko ^d   Doecke, James D ^a   Pasco, Julie ^e   Fozzard, Nicolette ^a   Jones, Graeme ^f   Ralston, Stuart H ^g   Sambrook, Philip N ^h   Prince, Richard L ⁱ   Nicholson, Geoff C ^j  

^a GRIFFITH UNIVERSITY   (Australia)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e DEAKIN UNIVERSITY   (Australia)

^f The Menzies Institute   (Australia)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^j UNIVERSITY OF QUEENSLAND   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE; TRANSCRIPTION FACTOR RUNX2; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; FEMALE; FEMUR NECK; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MUTATIONAL ANALYSIS; MUTATOR GENE; RUNX2 GENE; TRANSACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BONE DENSITY; CLEIDOCRANIAL DYSPLASIA; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; FEMORAL NECK FRACTURES; FEMUR NECK; GENETIC PREDISPOSITION TO DISEASE; GLUTAMINE; HEK293 CELLS; HUMANS; MICE; MONTE CARLO METHOD; MUTATION; NIH 3T3 CELLS; RECEPTORS, CALCITRIOL; REPETITIVE SEQUENCES, AMINO ACID; TRANSCRIPTIONAL ACTIVATION;

EID: 84865060439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042617     Document Type: Article

References (49)

1. McGuigan FE, Murray L, Gallagher A, Davey-Smith G, Neville CE, et al. (2002) Genetic and environmental determinants of peak bone mass in young men and women. J Bone Miner Res 17: 1273-1279.
2. Kanis JA, Melton LJ III, Christiansen J, Johnston CC, Khaltaev N, (1994) The diagnosis of osteoporosis. J Bone Miner Res 9: 1137-1141.
3. Chan MY, Nguyen ND, Center JR, Eisman JA, Nguyen TV, (2012) Absolute fracture-risk prediction by a combination of calcaneal quantitative ultrasound and bone mineral density. Calcif Tissue Int 90: 128-136.
4. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
5. Komori T, Yagi H, Nomura S, Yamaguchi A, et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
6. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, et al. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
7. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, et al. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773-779.
8. Enomoto H, Enomoto-Iwamoto M, Iwamoto M, Nomura S, Himeno M, et al. (2000) Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275: 8695-8702.
9. Vaughan T, Pasco JA, Kotowicz MA, Nicholson GC, Morrison NA, (2002) Alleles of RUNX2/CBFA1 gene are associated with differences in bone mineral density and risk of fracture. J Bone Miner Res 17: 1527-1534.
10. Vaughan T, Reid DM, Morrison NA, Ralston SH, (2004) RUNX2 alleles associated with BMD in Scottish women; interaction of RUNX2 alleles with menopausal status and body mass index. Bone 34: 1029-1036.
11. Napierala D, Garcia-Rojas X, Sam K, Wakui K, Chen C, et al. (2005) Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation. Mol Genet Metab 86: 257-268.
12. Doecke JD, Day CJ, Stephens AS, Carter SL, van Daal A, et al. (2006) Association of functionally different RUNX2 P2 promoter alleles with BMD. J Bone Miner Res 21: 265-273.
13. Bustamante M, Nogués X, Agueda L, Jurado S, Wesselius A, et al. (2007) Promoter 2-1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck BMD in Spanish postmenopausal women. Calcif Tissue Int 81: 327-332.
14. Ermakov S, Malkin I, Keter M, Kobyliansky E, Livshits G, (2008) Family based association study of polymorphisms in the RUNX2 locus with hand bone length and hand BMD. Ann Hum Genet 72: 510-518.
15. Lee HJ, Koh JM, Hwang JY, Choi KY, Lee SH, et al. (2009) Association of a RUNX2 promoter polymorphism with bone mineral density in postmenopausal Korean women. Calcif Tissue Int 84: 439-445.
16. Long F, (2011) Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 13: 27-38.
17. Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) (2012) World Wide Web URL: http://omim.org/#119600, CLEIDOCRANIAL DYSPLASIA; CCD.
18. Cohen MM Jr, (2009) Perspectives on RUNX genes: an update. Am J Med Genet 149: 2629-2646.
19. Yoshida T, Kanegane H, Osato M, Yanagida M, et al. (2002) Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am J Hum Genet 71: 724-738.
20. Zhang YW, Yasui N, Kakazu N, Abe T, Takada K, et al. (2000) PEBP2alphaA/CBFA1 mutations in Japanese cleidocranial dysplasia patients. Gene 244: 21-28.
21. McMurray CT, (2010) Mechanisms of trinucleotide repeat instability during human development. Nat Rev Genet 11: 786-799.
22. Pineda B, Hermenegildo C, Laporta P, Tarín JJ, Cano A, et al. (2010) Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women. J Bone Miner Metab 28: 696-705.
23. Fondon JW 3rd, Garner HR, (2004) Molecular origins of rapid and continuous morphological evolution. Proc Natl Acad Sci USA 101: 18058-18063.
24. Sears KE, Goswami A, Flynn JJ, Niswander LA, (2007) The correlated evolution of Runx2 tandem repeats, transcriptional activity, and facial length in carnivora. Evol Dev 9: 555-565.
25. Prince RL, Devine A, Dhaliwal SS, Dick IM, (2006) Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166: 869-875.
26. Henry MJ, Pasco JA, Nicholson GC, Seeman E, Kotowicz MA, (2000) Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study. J Clin Densitom 3: 261-268.
27. Sanders KM, Seeman E, Ugoni AM, Pasco JA, Martin TJ, et al. (1999) The age- and gender-specific rate of fractures in Australia: a population based study. Osteoporosis Int 10: 240-247.
28. Makovey J, Nguyen TV, Naganathan V, Wark JD, Sambrook PN, (2007) Genetic effects on bone loss in peri- and postmenopausal women: a longitudinal twin study. J Bone Miner Res 22: 1773-1780.
29. Ding C, Parameswaran V, Cicuttini F, Burgess J, Zhai G, et al. (2008) Association between leptin, body composition, sex and knee cartilage morphology in older adults: the Tasmanian older adult cohort (TASOAC) study. Ann Rheum Dis 67: 1256-1261.
30. MacDonald HM, McGuigan FA, New SA, Campbell MK, Golden MHN, et al. (2001) COL1A1 Sp1 polymorphism predicts perimenopausal and early postmenopausal spinal bone loss. J Bone Miner Res 16: 1634-1641.
31. Tilyard MW, Spears GF, Thomson J, Dovey S, (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326: 357-362.
32. Morrison NA, George PM, Vaughan T, Tilyard MW, Frampton CM, et al. (2005) Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis. Pharmacogenet Genomics 15: 127-135.
33. Zhang YW, Yasui N, Ito K, Huang G, Fujii M, et al. (2000) A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97: 10549-10554.
34. Mizushima S, Nagata S, (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18: 5322.
35. Yoshida T, Kanegane H, Osato M, Yanagida M, Miyawaki T, et al. (2002) Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am J Hum Genet 71: 724-738.
36. Dyer BW, Ferrer FA, Klinedinst DK, Rodriguez R, (2000) A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 282: 158-161.
37. Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, et al. (2000) VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J 14: 1455-1463.
38. Hood GM (2010) PopTools version 3.2.3 (CSIRO Canberra, Australia). Available on the internet. URL http://www.poptools.org.
39. Pasco JA, Seeman E, Henry MJ, Merriman EN, Nicholson GC, et al. (2006) The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int 17: 1404-1409.
40. Finsterer J, (2010) Perspectives of Kennedy's disease. J Neurol Sci 298: 1-10.
41. Chamberlain NL, Driver ED, Miesfeld RL, (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22: 3181-3186.
42. Perutz MF, Finch JT, Berriman J, Lesk A, (2002) Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci USA 99: 5591-5595.
43. Ogawa H, Nakano M, Watanabe H, Starikov EB, Rothstein SM, et al. (2008) Molecular dynamics simulation study on the structural stabilities of polyglutamine peptides. Comput Biol Chem 32: 102-110.
44. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, et al. (2004) Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24: 8847-8861.
45. Atanesyan L, Nther V, Dichtl B, Georgiev O, Schaffner W, (2012) Polyglutamine tracts as modulators of transcriptional activation from yeast to mammals. Biol Chem 393: 63-70.
46. Whan V, Hobbs M, McWilliam S, Lynn DJ, Lutzow YS, et al. (2010) Bovine proteins containing poly-glutamine repeats are often polymorphic and enriched for components of transcriptional regulatory complexes. BMC Genomics 11: 654-665.
47. Green RE, Krause J, Briggs AW, Maricic T, Stenzel U, et al. (2010) A draft sequence of the Neandertal genome. Science 328: 710-722.
48. Kanatani N, Fujita T, Fukuyama R, Liu W, Yoshida CA, et al. (2006) Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development. Dev Biol 296: 48-61.
49. Xiao Z, Awad HA, Liu S, Mahlios J, Zhang S, et al. (2005) Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice. Dev Biol 283: 345-356.